[Experimental investigations on drug induced improvement of brain metabolism].
D000328:Adult; D000368:Aged; D001812:Blood-Brain Barrier / Q000187:drug effects; D001921:Brain / Q000378:metabolism*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy; D011581:Psychological Tests; D011594:Psychometrics; D011726:Pyridinium Compounds / Q000494:pharmacology; D013805:Theobromine / Q000494:pharmacology* / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000627:therapeutic use; D014970:Xanthines / Q000494:pharmacology* / Q000627:therapeutic use
D011726:Pyridinium Compounds; D014665:Vasodilator Agents; D014970:Xanthines; D013805:Theobromine
Experimentelle Resultate unter pharmakologisch gefördertem Hirnstoffwechsel.